Bessemer Group Inc. Sells 3,645 Shares of Encompass Health Co. (NYSE:EHC)

Bessemer Group Inc. trimmed its stake in shares of Encompass Health Co. (NYSE:EHC - Free Report) by 8.1% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 41,095 shares of the company's stock after selling 3,645 shares during the quarter. Bessemer Group Inc.'s holdings in Encompass Health were worth $3,796,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors also recently modified their holdings of the company. MassMutual Private Wealth & Trust FSB lifted its holdings in shares of Encompass Health by 87.8% during the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company's stock valued at $27,000 after acquiring an additional 137 shares during the period. CBIZ Investment Advisory Services LLC boosted its position in Encompass Health by 38.7% in the fourth quarter. CBIZ Investment Advisory Services LLC now owns 455 shares of the company's stock valued at $42,000 after buying an additional 127 shares in the last quarter. Tompkins Financial Corp bought a new stake in Encompass Health during the fourth quarter worth about $46,000. V Square Quantitative Management LLC increased its holdings in shares of Encompass Health by 43.8% during the fourth quarter. V Square Quantitative Management LLC now owns 581 shares of the company's stock worth $54,000 after buying an additional 177 shares in the last quarter. Finally, Morse Asset Management Inc bought a new position in shares of Encompass Health in the third quarter valued at approximately $68,000. 97.25% of the stock is currently owned by institutional investors.

Encompass Health Trading Down 0.9 %

EHC traded down $0.96 during midday trading on Tuesday, reaching $102.30. 775,382 shares of the company were exchanged, compared to its average volume of 662,645. The company has a debt-to-equity ratio of 0.84, a quick ratio of 1.04 and a current ratio of 1.05. The stock has a market capitalization of $10.30 billion, a P/E ratio of 22.94, a PEG ratio of 2.31 and a beta of 0.87. The stock's 50-day simple moving average is $99.66 and its 200 day simple moving average is $98.11. Encompass Health Co. has a one year low of $78.53 and a one year high of $105.23.

Remove Ads

Encompass Health (NYSE:EHC - Get Free Report) last issued its earnings results on Thursday, February 6th. The company reported $1.17 EPS for the quarter, beating the consensus estimate of $1.05 by $0.12. Encompass Health had a net margin of 8.48% and a return on equity of 17.56%. As a group, analysts forecast that Encompass Health Co. will post 4.8 earnings per share for the current fiscal year.

Encompass Health Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, April 15th. Stockholders of record on Tuesday, April 1st will be given a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a dividend yield of 0.66%. The ex-dividend date is Tuesday, April 1st. Encompass Health's dividend payout ratio is currently 15.25%.

Analyst Ratings Changes

A number of equities research analysts recently commented on EHC shares. StockNews.com lowered Encompass Health from a "buy" rating to a "hold" rating in a research report on Thursday, April 3rd. Barclays raised their target price on Encompass Health from $116.00 to $118.00 and gave the company an "overweight" rating in a research note on Friday, February 7th. William Blair reaffirmed an "outperform" rating on shares of Encompass Health in a report on Friday, February 7th. Royal Bank of Canada reissued an "outperform" rating and set a $110.00 price objective on shares of Encompass Health in a report on Tuesday, February 11th. Finally, KeyCorp boosted their target price on shares of Encompass Health from $117.00 to $120.00 and gave the stock an "overweight" rating in a research note on Monday, February 10th. One analyst has rated the stock with a hold rating, nine have given a buy rating and two have given a strong buy rating to the company's stock. According to data from MarketBeat.com, Encompass Health currently has an average rating of "Buy" and a consensus price target of $107.67.

Insider Activity at Encompass Health

In related news, CAO Andrew L. Price sold 5,042 shares of the firm's stock in a transaction on Thursday, February 13th. The shares were sold at an average price of $98.29, for a total transaction of $495,578.18. Following the sale, the chief accounting officer now directly owns 69,164 shares in the company, valued at $6,798,129.56. This trade represents a 6.79 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. 2.10% of the stock is owned by insiders.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.